by Parker Advocaten | 23 November 2020 | Privacy
Last summer, the European Court of Justice ruled in the Schrems II case that US national law does not provide a level of protection essentially equivalent to that guaranteed in the EU. National law allows US government authorities to access personal data transferred from the EU to the US for national security purposes.
read more
by Parker Advocaten | 25 September 2020 | Pharma & Life Sciences
Although E-health is a major spearhead in healthcare, there are also forms of digital care that are under scrutiny and have meanwhile been found impermissible by the court.
read more
by Micheline Don & Parker Advocaten | 23 June 2020 | Intellectual Property
Under ‘portrait law’ the appearance of a person is protected and one should not simply use a recognizable image of someone else. If this does happen, then the person portrayed may oppose this, provided he has a reasonable interest in this.
read more
by Micheline Don & Parker Advocaten | 17 March 2020 | Intellectual Property
News A Jingle as Trademark? 17 March 2020 – Silvie Wertwijn, Micheline Don Last year we already informed in our Newsletter that since March 2019 registration of a mark no longer requires graphical representation. However, the condition that the mark... read more
by Parker Advocaten | 25 April 2019 | Pharma & Life Sciences
In our newsletter of April 2017, the Bill for review of the Dutch Medicines Act (DMA) by reason of technical improvements and increase of the fine maximum was already discussed. The final Act was published on 15 November 2018 and entered into force on 1 January 2019.
read more